✦ LIBER ✦

Coeliac disease and insulin dependent diabetes mellitus: One year follow-up report

✍ Scribed by I. De Vitis; G. D'Agostino; S. D'Addesa; P. Cotroneo; M. Cagnoni; M. Pompili; V. Festa; G. Ghirlanda; G.B. Gasbarrini

Book ID: 118878741
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 169 KB
Volume: 108
Category: Article
ISSN: 0016-5085
DOI: 10.1016/0016-5085(95)22710-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Insulin-dependent diabetes mellitus and

Insulin-dependent diabetes mellitus and coeliac disease

✍ Cornelius C Cronin; Fergus Shanahan 📂 Article 📅 1997 🏛 The Lancet 🌐 English ⚖ 25 KB

Coeliac disease and insulin-dependent di

Coeliac disease and insulin-dependent diabetes mellitus

✍ Helen R Gillet; Anne Ferguson 📂 Article 📅 1997 🏛 The Lancet 🌐 English ⚖ 20 KB

Celiac disease and type I (Insulin-Depen

Celiac disease and type I (Insulin-Dependent) diabetes mellitus in childhood: Follow-up study

✍ Renata Lorini; M. Serenella Scotta; Luigia Cortona; M. Antonietta Avanzini; Leti 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 436 KB

Coeliac Disease: Frequent Occurrence Aft

Coeliac Disease: Frequent Occurrence After Clinical Onset of Insulin-dependent Diabetes Mellitus

✍ T. Saukkonen; E. Savilahti; H. Reijonen; J. Ilonen; E. Tuomilehto-Wolf; H.K. Åke 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 639 KB

H. Pylori re-infection in insulin depend

H. Pylori re-infection in insulin dependent diabetes mellitus patients: A five year follow-up

✍ V. Ojetti; D. Pitocco; A. Migneco; M. Santoro; E.C. Nista; G. Gasbarrini; G. Ghi 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 266 KB

Five-year follow-up of islet cell antibo

Five-year follow-up of islet cell antibodies in Type 2 (non-insulin-dependent) diabetes mellitus

✍ L. Niskanen; J. Karjalainen; H. Sarlund; O. Siitonen; M. Uusitupa 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 799 KB

The aim was to study the frequency and appearance of cytoplasmic islet cell antibodies in relation to impairment of insulin secretory capacity and some clinical characteristics in a representative group of middle-aged (45-64 years) patients with Type 2 (non-insulin-dependent) diabetes mellitus (70 m